New Issue: NeurogesX to raise $25 million in private placement of shares

By Devika Patel

Knoxville, Tenn., Dec. 26 - NeurogesX, Inc. said it entered into an agreement on Dec. 23 for a $25 million private placement of stock.

The company will sell 4,020,910 common shares at $6.18 apiece. The shares are accompanied by warrants to buy 1,206,273 shares at $8.034 apiece for five years. The warrants were bought at $0.125 per underlying share.

Pacific Growth Equities, LLC was the agent.

Based in San Carlos, Calif., NeurogesX is a privately held specialty pharmaceutical company focused on neuropathic pain.

Issuer:	NeurogesX, Inc.
Issue:	Common stock
Amount:	$25 million
Shares:	4,020,910
Price:	$6.18
Warrants:	For 1,206,273 shares
Warrant expiration:	Five years
Warrant strike price:	$8.034
Agent:	Pacific Growth Equities, LLC
Settlement date:	Dec. 23
Stock symbol:	Nasdaq: NGSX
Stock price:	$6.18 at close Dec. 21

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.